Argenx Se (ARGX) intrinsic value & 10-year financials

Argenx Se (ARGX) has a Graham intrinsic value of €650.03 per share. Over the last 10 fiscal years revenue grew 87.2% a year to €4.2B, with an average return on invested capital of -14.2%.

Graham intrinsic value
€650.03
Revenue (FY2025)
€4.2B
Revenue growth (10-yr CAGR)
87.2%
ROIC (10-yr avg)
-14.2%
Free cash flow (FY2025)
€679.0M

ARGX 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 €4.2B €1.3B €19.57 €679.0M 25.4% 16.4%
FY2024 €2.2B €833.0M €12.78 -€84.5M -1.0% -1.1%
FY2023 €1.2B -€295.1M -€5.16 -€421.1M -35.7% -20.0%
FY2022 €400.7M -€709.6M -€13.05 -€863.6M -179.8% -26.2%
FY2021 €497.3M -€408.3M -€7.99 -€610.4M -70.1% -16.6%
FY2020 €36.4M -€608.5M -€13.40 -€399.5M -1311.2% -33.5%
FY2019 €69.8M -€163.0M -€4.69 €149.8M -285.0% -22.1%
FY2018 €21.5M -€66.6M — — -381.0% -10.8%
FY2017 €36.4M -€28.1M — — — —
FY2016 €14.7M — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in EUR.

Executive summary

ARGENX SE is a consistent compounder, expanding top-line revenue at 87.2% annually over the past decade.

ARGENX SE has historically struggled to out-earn its cost of capital, averaging just -14.2% ROIC.

ARGENX SE has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, ARGENX SE is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $650.03 per share.

ARGX stock: frequently asked questions

What is the intrinsic value of Argenx Se (ARGX) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 15.0% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, ARGX's intrinsic value is about €650.03 per share.

How fast has Argenx Se grown?

Revenue went from €14.7M in fiscal 2016 to €4.2B in fiscal 2025, a compound annual growth rate of 87.2%. Net income was €1.3B in fiscal 2025.

Does Argenx Se generate free cash flow?

Argenx Se generated €679.0M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 2 of the last 7 reported years.

What is ARGX's return on invested capital?

Average ROIC over the last 10 fiscal years was -14.2%, and average return on equity was -11.1%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this ARGX data come from?

From Argenx Se's annual 10-K filings on SEC EDGAR, most recently filed Mar 19, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar biological products stocks